Gene-specific ACMG/AMP classification criteria for germline APC variants: Recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert PanelMedical Genetics Center Munich, MGZ Munich, Germany.
Baylor College of Medicine, Houston, TX; Texas Children's Cancer Center, Texas Children's Hospital, Houston, USA.
Department of Oncological Sciences, School of Medicine, University of Utah, Salt Lake City, USA.
Hereditary Cancer Program, Catalan Institute of Oncology - ONCOBELL, IDIBELL, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.
epartment of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Greenwood Genetic Center, Greenwood, SC, USA.
Colorectal Oncogenomics Group, Department of Clinical Pathology, University of Melbourne, Parkville, Australia; Melbourne Bioinformatics, University of Melbourne, Parkville, Australia.
Department of Colorectal Medicine and Genetics, Royal Melbourne Hospital, Parkville, Australia.
Haukeland University Hospital, Bergen, Norway.
Linköping University, Department of Biomedical and Clinical Sciences, The Division of Cell and Neurobiology. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Center for Diagnostics, Clinical genetics.
Cancer Research UK Edinburgh Centre, the University of Edinburgh, Edinburgh, United Kingdom.
Department of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Saitama, Japan.
Department of Genetics, Rouen University Hospital, Rouen, France.
Department of Genetics, Rouen University Hospital, Rouen, France.
Invitae, San Francisco, CA.
Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
GeneDx, Gaithersburg, MD.
Peter MacCallum Cancer Centre, Melbourne, Australia.
Fondazione Policlinico Universitario A. Gemelli IRCCS, and Dipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy.
Ambry Genetics, Aliso Viejo, CA, USA.
European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) - Project ID No 739547; Hereditary Cancer Program, Catalan Institute of Oncology - ONCOBELL, IDIBELL, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.
Department of Oncological Sciences, School of Medicine, University of Utah, Salt Lake City, UT; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Polyposis Registry, St. Mark's Hospital, London, United Kingdom; Department of Surgery and Cancer, Imperial College, London, United Kingdom.
Polyposis Registry, St. Mark's Hospital, London, United Kingdom; Inherited Tumour Syndromes Research Group, Institute of Cancer & Genetics, Cardiff University, United Kingdom.
Baylor College of Medicine, Houston, TX; Texas Children's Cancer Center, Texas Children's Hospital, Houston, TX, USA.
Larner College of Medicine, University of Vermont, Burlington, VT, USA.
Department of Colorectal Medicine and Genetics, Royal Melbourne Hospital, Parkville, Australia; Department of Medicine, University of Melbourne, Parkville, Australia.
Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
Show others and affiliations
2024 (English)In: Genetics in Medicine, ISSN 1098-3600, E-ISSN 1530-0366, Vol. 26, no 2, article id 100992Article in journal (Refereed) Published
Abstract [en]
Purpose: The Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel (VCEP) was established by the International Society for Gastrointestinal Hereditary Tumours and the Clinical Genome Resource, who set out to develop recommendations for the interpretation of germline APC variants underlying Familial Adenomatous Polyposis, the most frequent hereditary polyposis syndrome. Methods: Through a rigorous process of database analysis, literature review, and expert elicitation, the APC VCEP derived gene-specific modifications to the ACMG/AMP (American College of Medical Genetics and Genomics and Association for Molecular Pathology) variant classification guidelines and validated such criteria through the pilot classification of 58 variants. Results: The APC-specific criteria represented gene- and disease-informed specifications, including a quantitative approach to allele frequency thresholds, a stepwise decision tool for truncating variants, and semiquantitative evaluations of experimental and clinical data. Using the APC-specific criteria, 47% (27/58) of pilot variants were reclassified including 14 previous variants of uncertain significance (VUS). Conclusion: The APC-specific ACMG/AMP criteria preserved the classification of well-characterized variants on ClinVar while substantially reducing the number of VUS by 56% (14/25). Moving forward, the APC VCEP will continue to interpret prioritized lists of VUS, the results of which will represent the most authoritative variant classification for widespread clinical use.
Place, publisher, year, edition, pages
Elsevier, 2024. Vol. 26, no 2, article id 100992
Keywords [en]
ACMG/AMP variant classification guidelines, Adenomatous polyposis coli (APC), ClinGen, Familial adenomatous polyposis (FAP), InSiGHT, Adenomatous Polyposis Coli, Genetic Testing, Genetic Variation, Germ Cells, Germ-Line Mutation, Humans, APC protein, bone morphogenetic protein receptor 1A, DNA glycosylase MutY, protein kinase LKB1, Smad4 protein, APC gene, Article, BMPR1A gene, cancer classification, computer model, controlled study, familial adenomatous polyposis, gene, gene frequency, gene function, gene identification, genetic association, genetic variability, germline mutation, hereditary colorectal cancer, human, human tissue, loss of function mutation, missense mutation, mutational analysis, MUTYH gene, POLD1 gene, POLE gene, predictive value, SMAD4 gene, STK11 gene, colon polyposis, genetic screening, genetics, germ cell, procedures
National Category
Medical Genetics and Genomics
Identifiers
URN: urn:nbn:se:liu:diva-211878DOI: 10.1016/j.gim.2023.100992ISI: 001178153300001PubMedID: 37800450Scopus ID: 2-s2.0-85179054274OAI: oai:DiVA.org:liu-211878DiVA, id: diva2:1941595
Note
Funding agencies: the Dutch Digestive Foundation (grant FP 16-01) and the Dutch Cancer Society (grant UL 20135939)
2025-03-012025-03-012026-03-13